We then questioned whether the experimental heterologous overexpression of NaV1.5 in weakly invasive and epithelial-type breast cancer cells, which do not express the protein endogenously, could promote EMT and increase invasiveness. The gene discussed is SCN5A; the disease is breast cancer.